E A Fallon1, D Driscoll2, T S Smith2, K Richardson2, K Portier2. 1. The American Cancer Society, 250 Williams Street, Atlanta, GA, 30004, USA. Elizabeth.Fallon@cancer.org. 2. The American Cancer Society, 250 Williams Street, Atlanta, GA, 30004, USA.
Abstract
PURPOSE: To describe (a) the conceptualization, purpose, and features of The American Cancer Society's Cancer Survivors Network® (CSN; http://csn.cancer.org ), (b) the ongoing two-phase evaluation process of CSN, and (c) the characteristics of CSN members. METHODS: An online opt-in self-report survey of CSN members (N = 4762) was conducted and digital metrics of site use were collected. RESULTS: Annually, CSN attracts over 3.6 million unique users from over 200 countries/territories. Most commonly used site features are discussion boards (81.1%), the search function (63.8%), and the member resource library (50.2%). The survey sample is mostly female (69.6%), non-Hispanic white (84.1%), and self-identified as a cancer survivor (49.8%), or both cancer survivor and cancer caregiver (31.9%). A larger number of survey respondents reported head and neck cancer (12.5%), relative to cancer incidence/prevalence data. CONCLUSIONS: The volume of CSN traffic suggests high demand among cancer survivors and caregivers for informational and/or emotional support from other cancer survivors and caregivers. CSN may be particularly beneficial for individuals with rare cancers. Furthermore, this study documents a group of individuals whose cancer experience is multifaceted (e.g., survivors became caregivers or vice versa), and for whom CSN has the capacity to provide support at multiple points during their cancer experiences. IMPLICATIONS FOR CANCER SURVIVORS: CSN is a free, internet-based social networking site available to all cancer survivors and caregivers, worldwide. Evaluation of the site is ongoing and will be used to inform improvements to usability, reach, recruitment, retention, and potential health impact(s) of this valuable resource.
PURPOSE: To describe (a) the conceptualization, purpose, and features of The American Cancer Society's Cancer Survivors Network® (CSN; http://csn.cancer.org ), (b) the ongoing two-phase evaluation process of CSN, and (c) the characteristics of CSN members. METHODS: An online opt-in self-report survey of CSN members (N = 4762) was conducted and digital metrics of site use were collected. RESULTS: Annually, CSN attracts over 3.6 million unique users from over 200 countries/territories. Most commonly used site features are discussion boards (81.1%), the search function (63.8%), and the member resource library (50.2%). The survey sample is mostly female (69.6%), non-Hispanic white (84.1%), and self-identified as a cancer survivor (49.8%), or both cancer survivor and cancer caregiver (31.9%). A larger number of survey respondents reported head and neck cancer (12.5%), relative to cancer incidence/prevalence data. CONCLUSIONS: The volume of CSN traffic suggests high demand among cancer survivors and caregivers for informational and/or emotional support from other cancer survivors and caregivers. CSN may be particularly beneficial for individuals with rare cancers. Furthermore, this study documents a group of individuals whose cancer experience is multifaceted (e.g., survivors became caregivers or vice versa), and for whom CSN has the capacity to provide support at multiple points during their cancer experiences. IMPLICATIONS FOR CANCER SURVIVORS: CSN is a free, internet-based social networking site available to all cancer survivors and caregivers, worldwide. Evaluation of the site is ongoing and will be used to inform improvements to usability, reach, recruitment, retention, and potential health impact(s) of this valuable resource.
Entities:
Keywords:
Cancer survivors (MeSH term); Evaluation studies (MeSH term); Internet (MeSH term); Neoplasm (MeSH term); Social networking (MeSH term); Social support (MeSH term)
Authors: Kang Zhao; John Yen; Greta Greer; Baojun Qiu; Prasenjit Mitra; Kenneth Portier Journal: J Am Med Inform Assoc Date: 2014-01-21 Impact factor: 4.497
Authors: Eric B Hekler; Susan Michie; Misha Pavel; Daniel E Rivera; Linda M Collins; Holly B Jimison; Claire Garnett; Skye Parral; Donna Spruijt-Metz Journal: Am J Prev Med Date: 2016-11 Impact factor: 5.043
Authors: M Gonzalez-Saenz de Tejada; A Bilbao; M Baré; E Briones; C Sarasqueta; J M Quintana; A Escobar Journal: Psychooncology Date: 2016-12-19 Impact factor: 3.894
Authors: Daniel Capurro; Kate Cole; Maria I Echavarría; Jonathan Joe; Tina Neogi; Anne M Turner Journal: J Med Internet Res Date: 2014-03-14 Impact factor: 5.428
Authors: Paul Hanly; Alan Ó Céilleachair; Mairead Skally; Eamonn O'Leary; Kanika Kapur; Patricia Fitzpatrick; Anthony Staines; Linda Sharp Journal: Support Care Cancer Date: 2013-05-07 Impact factor: 3.603
Authors: Stephen J Lepore; Maria A Rincon; Joanne S Buzaglo; Mitch Golant; Morton A Lieberman; Sarah Bauerle Bass; Suzanne Chambers Journal: Eur J Cancer Care (Engl) Date: 2019-07 Impact factor: 2.520
Authors: Pragya G Poudel; Hailey E Bauer; D Kumar Srivastava; Kevin R Krull; Melissa M Hudson; Leslie L Robison; Zhaoming Wang; I-Chan Huang Journal: JCO Clin Cancer Inform Date: 2021-08
Authors: Elizabeth J Adams; David Tallman; Marcy L Haynam; Larissa Nekhlyudov; Maryam B Lustberg Journal: J Med Internet Res Date: 2022-09-20 Impact factor: 7.076